Turn Therapeutics (TTRX) announces that its common stock is scheduled to commence trading, October 8, 2025, on the Nasdaq Capital Market under ticker symbol “TTRX.” The Company’s registration statement on Form S-1 was declared effective by the U.S. Securities and Exchange Commission September 30, 2025. Clear Street served as financial advisor to the company. Davis, Polk, and Wardwell acted as legal counsel.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off